iBio, Inc. (IBIO) Social Stream



iBio, Inc. (IBIO): $0.28

0.00 (-1.31%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add IBIO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 422

in industry

iBio Inc (IBIO) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering iBio Inc.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-04 1 $3 $3 $3 $0.435 589.66%
2021-11-29 2 $3 $1.5 $2.25 $0.435 417.24%
2022-02-15 2 $2.5 $1.5 $2 $0.435 359.77%

Over the past 134 days, IBIO's average upside potential has been 248.66%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-10-04 2 3.0 3.0 3.00 0.992 202.42%
2021-10-04 1 3.0 3.0 3.00 0.992 202.42%
2021-11-29 2 3.0 1.5 2.25 0.854 163.47%
2022-02-15 2 2.5 1.5 2.00 0.380 426.32%

IBIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 2 0 0 0 0 2

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • IBIO has a higher average analyst price target than 3.12% of all US stocks.
  • In terms of how iBio Inc fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 14.01% of that group.
  • In terms of how iBio Inc fares relative to stocks in the small market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 352.2% of that group.
  • In terms of how iBio Inc fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -43.83% of that group.

Stocks similar to iBio Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are HTBX, HROW, and HOWL.

Make investment decisions regarding IBIO using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4158 seconds.